Unilever Extends Collaboration with Transinsight in the Field of Semantic Searching

GoPubMedUnilever, one of the world's largest consumer products companies, will continue working with Transinsight towards a tailored solution from GoPubMed that meets Unilever Research's diverse scientific data mining requirements. Today's searching is mostly split between Internet and intranet searches. The integration of both worlds under one semantic umbrella is the goal of a continuing collaboration between Unilever and Transinsight, provider of solutions for knowledge-based semantic search technology. Unilever has chosen Transinsight for corporate semantic searching.

"GoPubMed is a fantastic semantic search engine that fits the needs of most users searching biomedical literature from the MEDLINE database. But we believe that the system can lead to a lot more insight and time saving if users get the chance to customise the underlying knowledge base so that the system can be used to search the Internet as well as our in-house data", says Wendy Filsell, a senior informatician in the Unilever Information Group. "For two years, GoPubMed has been in use at Unilever with great success in the fields of nutrition and metabolism, among others. We believe continuing to walk the road paved with semantic technologies from Transinsight will bring us better insights much faster."

Transinsight's search technology is made for the next generation of semantic searching. Its power lies in its ability to intelligently match huge amounts of textual material to very big classification networks like the Gene Ontology, MeSH or customer-tailored ontologies according to company needs. "Where traditional techniques take months we need only a few days," says Dr. Liliana Barrio-Alvers, CTO of Transinsight. She continues, "We are proud to have developed a technology that is unparalleled worldwide when it comes to meaningful semantic searches. Transinsight's core algorithms allow our customers to speed up their tedious daily work significantly because the search results are sorted in a smart way."

The free search platform www.GoPubMed.com will benefit from the collaboration between Unilever and Transinsight since both parties have agreed to include many of the jointly developed features in the open search platform. "We know that GoPubMed helps the biomedical community when it comes to getting answers for more and more complex questions. The Wikipedia-like collaboration applied to the knowledge-network makes the search more intelligent every day since the users improve it for the benefit of themselves and others", says Dr. Michael R. Alvers, CEO of Transinsight.

Related news articles:

About Unilever
Unilever's mission is to add vitality to life. We meet everyday needs for nutrition, hygiene and personal care with brands that help people feel good, look good and get more out of life. Unilever is one of the world's leading suppliers of fast moving consumer goods with strong local roots in more than 100 countries across the globe. Its portfolio includes some of the world's best known and most loved brands including twelve €1 billion brands and global leadership in many categories in which the company operates. The portfolio features brand icons such as Flora/Becel, Bertolli, Dove, Lux, Pond's, Lynx, Sunsilk, Omo, Cif and Domestos. Unilever has around 179,000 employees in nearly 100 countries and generated annual sales of €40 billion in 2006. For more information about Unilever and its brands, visit www.unilever.com.

About Transinsight
Founded in 2005, Transinsight is focused on software solutions for the life sciences providing products for knowledge-based technologies. The flagship product, www.gopubmed.com, a well established biomedical search engine, is the first knowledge-based search engine for the Life Sciences on the Internet. Transinsight is headquartered in one of the leading German biotech incubators, the BioInnovationCenter Dresden BIOZ, where science and business work under one roof. Transinsight works in close collaboration with the Technical University Dresden. For further information, visit www.transinsight.com.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...